Researchers identified lymphatic retinol binding protein 1 (RBP1) as a driver of metastatic dissemination in triple-negative breast cancer. The study reported that tumor-associated lymphatic vessels upregulated RBP1, promoting lymphangiogenesis and metabolic rewiring that supported metastasis, mapping a potentially targetable axis within the tumor lymphatic microenvironment.